Hormonal Regulation of Fuel Metabolism

Overview of Fuel Metabolism

Fuel metabolism in the human body is tightly regulated to ensure that each organ receives the energy it needs. The main organs involved include the brain, muscle, liver, adipose tissue, and heart. Each organ has distinct fuel reserves, preferred fuels, and metabolic roles.

• Brain: Requires ~120 g/day of glucose, has no fuel reserves, and uses glucose exclusively.

• Skeletal Muscle: Stores glycogen and protein; prefers fatty acids during rest and glucose during exercise; produces lactic acid during anaerobic activity.

• Heart Muscle: Highly aerobic, prefers fatty acids, minimal energy reserves (creatine phosphate).

• Adipose Tissue: Stores triglycerides (three fatty acids on a glycerol backbone); exports fatty acids and glycerol.

• Liver: Central metabolic organ; stores glycogen and triglycerides; exports glucose, fatty acids, and ketone bodies.

Additional info: The circulatory system connects all organs, facilitating the transport of fuels and metabolic intermediates.

Fuel Characteristics and Organ Preferences

Each organ's fuel preference and metabolic activity are determined by its function and energy demands.

• Brain: Consumes 60% of resting glucose intake; 20% of total oxygen consumption.

• Muscle: Uses fatty acids at rest; switches to glucose and produces lactate during exertion.

• Heart: Requires continuous oxygen supply; uses fatty acids.

• Liver: Buffers blood glucose via high KM glucokinase and controls glucose transporter location.

• Adipose Tissue: Major energy depot; stores enough calories for 2-3 months.

Key Metabolic Pathways

• Glycogenolysis: Breakdown of glycogen to glucose.

• Gluconeogenesis: Synthesis of glucose from non-carbohydrate sources (e.g., pyruvate, alanine).

• Fatty Acid Oxidation: Breakdown of fatty acids for energy.

• Pentose Phosphate Pathway: Generates ribose and NADPH for biosynthetic reactions.

Hormonal Regulation of Metabolism

Major Hormones: Insulin, Glucagon, and Epinephrine

Three key hormones regulate fuel metabolism and maintain blood glucose homeostasis:

• Insulin: Released in response to high blood glucose; promotes glucose uptake, glycogen synthesis, and fatty acid synthesis.

• Glucagon: Released in response to low blood glucose; stimulates glycogen breakdown and gluconeogenesis in the liver.

• Epinephrine: Released during stress; stimulates glucose release from the liver and mobilizes fatty acids from adipose tissue.

Hormonal Actions and Enzyme Targets

• Insulin:

  • Targets GLUT4 (glucose transporter) to enable glucose uptake.

  • Activates PFK-1 (phosphofructokinase-1) to stimulate glycolysis.

  • Promotes glycogen synthase and fatty acid synthesis.

• Glucagon:

  • Stimulates glycogen phosphorylase for glycogenolysis.

  • Activates gluconeogenesis via upregulation of key enzymes.

• Epinephrine:

  • Mobilizes triglycerides via hormone-sensitive lipases.

  • Stimulates glycogenolysis and inhibits insulin secretion.

  • Effects are short-lived compared to glucagon.

Enzyme Regulation and Pathway Directionality

Hormones regulate metabolic pathways by activating or inhibiting specific enzymes. Understanding the direction of regulation is more important than memorizing enzyme names.

• High blood glucose: Insulin promotes glucose uptake and storage.

• Low blood glucose: Glucagon and epinephrine promote glucose release and alternative fuel utilization.

Cellular Signaling and Metabolic Sensors

AMP-Activated Protein Kinase (AMPK)

AMPK is activated under low energy conditions (high AMP/low ATP) and stimulates pathways that produce ATP while inhibiting ATP-consuming pathways.

• Promotes glucose uptake and fatty acid oxidation.

• Inhibits biosynthetic pathways (e.g., lipid synthesis).

mTOR (Mammalian Target of Rapamycin)

mTOR is a serine/threonine protein kinase activated under nutrient-rich conditions. It promotes cell proliferation, protein synthesis, and lipid biosynthesis.

• Activated by amino acid and glucose availability.

• Dysregulated in cancer, leading to uncontrolled cell growth.

Sirtuins

Sirtuins are NAD+-dependent protein deacetylases that sense cellular redox state and energy levels. They regulate metabolic reprogramming by deacetylating proteins such as PGC-1α, upregulating gluconeogenesis and mitochondrial biogenesis.

Interplay Between AMPK and mTOR

AMPK and mTOR inhibit each other, balancing energy production and biosynthesis based on nutrient availability.

Metabolic Regulation in Health and Disease

Diabetes Mellitus: Type 1 and Type 2

Diabetes is characterized by impaired regulation of blood glucose.

• Type 1 Diabetes: Autoimmune destruction of insulin-producing cells; requires insulin therapy.

• Type 2 Diabetes: Develops over time; associated with insulin resistance and obesity; managed by diet, exercise, and medications.

Metabolic abnormalities include impaired glucose uptake in muscle and adipose tissue, increased protein degradation, and mobilization of fatty acids leading to ketone body production.

Summary Table: Organ Fuel Preferences and Metabolic Roles

Key Equations and Concepts

Michaelis-Menten Constant (KM)

The KM value of an enzyme reflects its affinity for substrate. High KM means low affinity, requiring higher substrate concentration for activity.

Glycolysis Net ATP Yield

In erythrocytes (no mitochondria), glycolysis yields a net of 2 ATP per glucose molecule.

Regulation of Gluconeogenesis

Key enzymes upregulated during gluconeogenesis:

• PEPCK (Phosphoenolpyruvate Carboxykinase): Converts oxaloacetate to phosphoenolpyruvate.

• Glucose-6-phosphatase: Removes phosphate from glucose-6-phosphate to yield free glucose.

Applications and Clinical Relevance

• Homeostasis: Hormonal regulation maintains blood glucose within a narrow range.

• Exercise: Muscle shifts from fatty acid to glucose utilization; lactate is recycled via the liver (Cori cycle).

• Diabetes: Understanding hormone action and metabolic pathways is essential for managing diabetes.

• Cancer Metabolism: Dysregulation of mTOR and preference for glycolysis (Warburg effect) in tumor cells.

Additional info: The Warburg effect describes cancer cells' tendency to use anaerobic glycolysis even in the presence of oxygen, producing lactate instead of pyruvate.